These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7507945

  • 21. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A, Kudo M, Ansai S, Peng WX, Ishino K, Yamamoto T, Wada R, Fujii T, Teduka K, Kawahara K, Kawamoto Y, Kitamura T, Kawana S, Saeki H, Naito Z.
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [Abstract] [Full Text] [Related]

  • 22. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Coklo M, Hadzisejdic I, Stemberger C, Zauhar G.
    Pathol Res Pract; 2006 Mar; 202(8):599-607. PubMed ID: 16781827
    [Abstract] [Full Text] [Related]

  • 23. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
    Fujii M, Honma M, Takahashi H, Ishida-Yamamoto A, Iizuka H.
    Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
    [Abstract] [Full Text] [Related]

  • 24. Expression of apoptosis-inducing factor (AIF) in keratoacanthomas and squamous cell carcinomas of the skin.
    Skyrlas A, Hantschke M, Passa V, Gaitanis G, Malamou-Mitsi V, Bassukas ID.
    Exp Dermatol; 2011 Aug; 20(8):674-6. PubMed ID: 21410769
    [Abstract] [Full Text] [Related]

  • 25. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Brumini G, Biljan D, Petranović D, Troselj-Vukić B.
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [Abstract] [Full Text] [Related]

  • 26. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R, Martínez-Barba E, López-Poveda MJ, Vidal-Abarca Gutiérrez I, Ruíz-Maciá JA, Oviedo-Ramirez I, Martínez-Menchón T.
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [Abstract] [Full Text] [Related]

  • 27. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Hadzisejdic I, Zauhar G.
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract] [Full Text] [Related]

  • 28. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
    Binder M, Steiner A, Mossbacher U, Hunegnaw M, Pehamberger H, Wolff K.
    Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
    [Abstract] [Full Text] [Related]

  • 29. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
    Cabrijan L, Lipozencić J, Batinac T, Lenković M, Zgombić ZS.
    Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
    [Abstract] [Full Text] [Related]

  • 30. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
    Sağol O, Kurtoğlu B, Ozer E, Pabuççuoğlu U.
    Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
    [Abstract] [Full Text] [Related]

  • 31. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. An immunohistochemical study of proliferating cell populations.
    Geary WA, Cooper PH.
    J Cutan Pathol; 1992 Dec; 19(6):458-68. PubMed ID: 1362576
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
    Cribier B, Asch P, Grosshans E.
    Dermatology; 1999 Dec; 199(3):208-12. PubMed ID: 10592399
    [Abstract] [Full Text] [Related]

  • 34. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
    Fraga GR, Chow P.
    J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
    [Abstract] [Full Text] [Related]

  • 35. Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.
    Honma M, Kato N, Hashimoto M, Takahashi H, Ishida-Yamamoto A, Iizuka H.
    Clin Exp Dermatol; 2011 Jan; 36(1):57-62. PubMed ID: 20456385
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
    Jacobs MS, Persons DL, Fraga GR.
    J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519
    [Abstract] [Full Text] [Related]

  • 38. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Soddu S, Di Felice E, Cabras S, Castellanos ME, Atzori L, Faa G, Pilloni L.
    Eur J Histochem; 2013 Feb 14; 57(1):e6. PubMed ID: 23549465
    [Abstract] [Full Text] [Related]

  • 39. Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA, Ross JS, Boehm JR, Carlson JA.
    J Cutan Pathol; 1999 Sep 14; 26(8):391-7. PubMed ID: 10551411
    [Abstract] [Full Text] [Related]

  • 40. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma.
    Klein-Szanto AJ, Barr RJ, Reiners JJ, Mamrack MD.
    Arch Pathol Lab Med; 1984 Nov 14; 108(11):888-90. PubMed ID: 6385922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.